Follow
Matthew D Galbraith
Matthew D Galbraith
Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus
Verified email at cuanschutz.edu
Title
Cited by
Cited by
Year
Transcriptional regulation by hypoxia inducible factors
VL Dengler, MD Galbraith, JM Espinosa
Critical reviews in biochemistry and molecular biology 49 (1), 1-15, 2014
8422014
Mechanisms of transcriptional regulation by p53
KD Sullivan, MD Galbraith, Z Andrysik, JM Espinosa
Cell Death & Differentiation 25 (1), 133-143, 2018
4312018
HIF1A Employs CDK8-Mediator to Stimulate RNAPII Elongation in Response to Hypoxia
MD Galbraith, MA Allen, CL Bensard, X Wang, MK Schwinn, B Qin, ...
Cell 153 (6), 1327-1339, 2013
3652013
Global analysis of p53-regulated transcription identifies its direct targets and unexpected regulatory mechanisms
MA Allen, Z Andrysik, VL Dengler, HS Mellert, A Guarnieri, JA Freeman, ...
Elife 3, e02200, 2014
2622014
CDK8: a positive regulator of transcription
MD Galbraith, AJ Donner, JM Espinosa
Transcription 1 (1), 4-12, 2010
2592010
Trisomy 21 consistently activates the interferon response
KD Sullivan, HC Lewis, AA Hill, A Pandey, LP Jackson, JM Cabral, ...
eLife 5, e16220, 2016
2562016
Identification of a core TP53 transcriptional program with highly distributed tumor suppressive activity
Z Andrysik, MD Galbraith, AL Guarnieri, S Zaccara, KD Sullivan, A Pandey, ...
Genome research 27 (10), 1645-1657, 2017
1412017
Mitogen-induced recruitment of ERK and MSK to SRE promoter complexes by ternary complex factor Elk-1
HM Zhang, L Li, N Papadopoulou, G Hodgson, E Evans, M Galbraith, ...
Nucleic acids research 36 (8), 2594-2607, 2008
1052008
Mass Cytometry Reveals Global Immune Remodeling with Multi-lineage Hypersensitivity to Type I Interferon in Down Syndrome
KA Waugh, P Araya, A Pandey, KR Jordan, KP Smith, RE Granrath, ...
Cell reports 29 (7), 1893-1908. e4, 2019
912019
The TIP60 Complex Is a Conserved Coactivator of HIF1A
JI Perez-Perri, VL Dengler, KA Audetat, A Pandey, EA Bonner, M Urh, ...
Cell Reports 16 (1), 37-47, 2016
912016
Therapeutic targeting of transcriptional cyclin-dependent kinases
MD Galbraith, H Bender, JM Espinosa
Transcription 10 (2), 118-136, 2019
822019
Biochemical and genetic diversity of pectolytic enterobacteria causing soft rot disease of potatoes in New Zealand
AR Pitman, PJ Wright, MD Galbraith, SA Harrow
Australasian Plant Pathology 37, 559-568, 2008
822008
CDK8 Kinase Activity Promotes Glycolysis
MD Galbraith, Z Andrysik, A Pandey, M Hoh, EA Bonner, AA Hill, ...
Cell Reports 21 (6), 1495-1506, 2017
802017
A kinase-independent role for cyclin-dependent kinase 19 in p53 response
KA Audetat, MD Galbraith, AT Odell, T Lee, A Pandey, JM Espinosa, ...
Molecular and cellular biology, 2017
772017
Specialized interferon action in COVID-19
MD Galbraith, KT Kinning, KD Sullivan, P Araya, KP Smith, RE Granrath, ...
Proceedings of the National Academy of Sciences 119 (11), e2116730119, 2022
732022
Mutual exclusivity of MED12/MED12L, MED13/13L, and CDK8/19 paralogs revealed within the CDK-Mediator kinase module
DL Daniels, M Ford, MK Schwinn, H Benink, MD Galbraith, ...
J Proteomics Bioinform S 2 (2), 2013
642013
Transcriptional Responses to IFN-γ Require Mediator Kinase-Dependent Pause Release and Mechanistically Distinct CDK8 and CDK19 Functions
I Steinparzer, V Sedlyarov, JD Rubin, K Eislmayr, MD Galbraith, ...
Molecular cell 76 (3), 485-499. e8, 2019
612019
Seroconversion stages COVID19 into distinct pathophysiological states
MD Galbraith, KT Kinning, KD Sullivan, R Baxter, P Araya, KR Jordan, ...
Elife 10, e65508, 2021
492021
Multi-omics analysis reveals contextual tumor suppressive and oncogenic gene modules within the acute hypoxic response
Z Andrysik, H Bender, MD Galbraith, JM Espinosa
Nature Communications 12 (1), 1375, 2021
412021
A DR4: tBID axis drives the p53 apoptotic response by promoting oligomerization of poised BAX
RE Henry, Z Andrysik, R París, MD Galbraith, JM Espinosa
The EMBO journal 31 (5), 1266-1278, 2012
412012
The system can't perform the operation now. Try again later.
Articles 1–20